对话分析
宏观分析
个别股票
Alpha 实验室
实用工具
Menu
ZH
登录
ZH
暴涨分析
/
U2Bio Co., Ltd.
/
2026-04-23
▲ SURGE
U2Bio Co., Ltd.
+17.3%
221800
KRX
Healthcare
2026-04-23
18,300
收盘价
15,600
前收盘价
+17.31%
涨幅
12.8x
量比
暴涨原因
没有相关新闻。
相关新闻
Uni-Bio Science to Update Articles for New HK Listing and Market Regimes
Tipranks
2026-03-27
New May data will show verekitug effects in nasal polyp patients
Stocktitan
2026-04-17
Unico Silver Grants Additional Performance Rights to Director Peter Canterbury
Tipranks
2026-04-08
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Au.Marketscreener
2026-04-17
iBio Q2 EPS $(0.09) Misses $(0.07) Estimate - iBio (NASDAQ:IBIO)
Benzinga
2026-02-10
技术分析
信号
MACD看跌
跌破SMA20
关键指标
50.38
RSI (14)
18670.00
SMA 20
14162.20
Bollinger Lower
23177.80
Bollinger Upper
18670.00
Bollinger Mid
-754.90
MACD
-576.00
MACD Signal
-178.90
MACD Hist
查看股票详情
返回暴涨股列表
U2Bio Co., Ltd. +17.3% 暴涨分析 (2026-04-23) | Alpha Lenz